Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorMOHAMMEDI, Kamel
hal.structure.identifierInstitut Cochin [IC UM3 (UMR 8104 / U1016)]
dc.contributor.authorBERTHERAT, Jerome
hal.structure.identifierCentre de Recherche en Cancérologie de Lyon [UNICANCER/CRCL]
dc.contributor.authorRAVEROT, Gerald
dc.contributor.authorDRUI, Delphine
dc.contributor.authorREZNIK, Yves
dc.contributor.authorCASTINETTI, Frederic
dc.contributor.authorCHANSON, Philippe
dc.contributor.authorFAFIN, Manon
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorBROSSAUD, Julie
dc.contributor.authorTABARIN, Antoine
dc.date.accessioned2023-12-06T14:59:10Z
dc.date.available2023-12-06T14:59:10Z
dc.date.issued2023-05-05
dc.identifier.issn0021-972Xen_US
dc.identifier.urioai:crossref.org:10.1210/clinem/dgad251
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/186411
dc.description.abstractEnContext: Cortisol-lowering drugs may not restore a normal cortisol secretion in Cushing disease (CD). Objective: This work aimed to assess the long-term cortisol exposure in medically treated CD patients using hair-cortisol (HF) and hair-cortisone (HE) measurement. Methods: This multicenter prospective study included 3 groups of female patients: CushMed = 16 treated with a stable cortisol-lowering drug dosage and normal urinary free cortisol (UFC); CushSurg = 13 cured by pituitary surgery; CushBla = 15 receiving stable recommended doses of hydrocortisone following bilateral adrenalectomy. Patients were evaluated for 3 months with their usual treatments. Two late-night saliva and 24-hour urine samples were collected monthly in CushMed, and at study end in CushSurg and CushBla patients. A 3-cm hair sample was collected at study end from all patients. Main outcome measures included clinical score and centralized measurement of UFC, late-night salivary cortisol (LNSF), late-night salivary cortisone (LNSE), HE, HF. Results: Despite having almost all UFCs normalized, CushMed patients exhibited increased HE as compared to CushSurg controls (P = .003). CushMed patients also had increased clinical score (P = .001), UFC (P = .03), LNSF, LNSE (P = .0001), and variability in the latter parameters (P = .004). CushBla patients had increased HF and HE, contrasting with LNSEs similar to CushSurg patients. Six of 15 CushMed patients exhibited increased HE concentrations and had increased antihypertensive drug dosage compared to CushMed patients with normal HE (P = .05). Conclusion: Despite normalized UFCs, a subset of medically treated CD patients displays an altered circadian rhythm of serum cortisol. A single HE measurement identifies chronic mild persistent hypercortisolism and could replace multiple saliva analyzes to monitor medical treatments in CD patients once UFC is normalized.
dc.language.isoENen_US
dc.sourcecrossref
dc.subject.enCushing disease
dc.subject.enHair cortisol
dc.subject.enHair cortisone
dc.subject.enPharmacological treatment
dc.subject.enBilateral adrenalectomy
dc.subject.enLate-night salivary cortisone
dc.title.enEvidence of Persistent Mild Hypercortisolism in Patients Medically Treated for Cushing Disease: the Haircush Study
dc.typeArticle de revueen_US
dc.identifier.doi10.1210/clinem/dgad251en_US
dc.subject.halSciences du Vivant [q-bio]/Neurosciences [q-bio.NC]en_US
dc.identifier.pubmed37144820en_US
bordeaux.journalJournal of Clinical Endocrinology and Metabolismen_US
bordeaux.pagee963-e970en_US
bordeaux.volume108en_US
bordeaux.hal.laboratoriesNutriNeuro (Laboratoire de Nutrition et Neurobiologie Intégrée) - UMR 1286en_US
bordeaux.issue10en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionBordeaux INPen_US
bordeaux.institutionINRAEen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcedissemin
hal.identifierhal-04327345
hal.version1
hal.date.transferred2023-12-06T14:59:12Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
workflow.import.sourcedissemin
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20Clinical%20Endocrinology%20and%20Metabolism&rft.date=2023-05-05&rft.volume=108&rft.issue=10&rft.spage=e963-e970&rft.epage=e963-e970&rft.eissn=0021-972X&rft.issn=0021-972X&rft.au=MOHAMMEDI,%20Kamel&BERTHERAT,%20Jerome&RAVEROT,%20Gerald&DRUI,%20Delphine&REZNIK,%20Yves&rft.genre=article


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée